Pavblu, an Eylea biosimilar, shows stable vision outcomes and minimal side effects in real-world use, promising a reliable ...

The authors of an opinion piece in The Lancet Psychiatry make a case for paying more attention to the autistic features of ...

International audience surveys from last year’s menopause documentary, The (M) Factor, shed light on the ongoing need for ...

Veena Joy, the U.S. autoimmunity lead for medical and scientific affairs at Thermo Fisher Scientific, discusses the latest in ...

Farxiga, along with insulin and monitoring for diabetic ketoacidosis, shows promise for kidney and glucose control in youth with Type 1 diabetes.

An expert discusses how clinics can successfully implement gene therapy workflows by establishing strong institutional protocols, assigning dedicated clinic coordinators, and using strategies like ...